Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3No longer available 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 11Triple Negative Breast Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Multiple Myeloma 2Meningeal Neoplasms 2Lymphoma, Non-Hodgkin 2HER2-positive Breast Cancer 2Stomach Neoplasms 1Rectal Neoplasms 1Pathologic Complete Response 1Meningeal Carcinomatosis 1Hemangiosarcoma 1Colorectal Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 38pembrolizumab 36Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 18Exercise 17Carboplatin 16Nivolumab 15atezolizumab 14Cisplatin 14Drug Therapy 13Paclitaxel 12Fluorouracil 12Cyclophosphamide 12Cetuximab 12Trastuzumab 10Leucovorin 10Docetaxel 10Dexamethasone 10Pemetrexed 9Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × tucatinib × Clear all
NCT02693535 2026-05-29

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting
4,200 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT01042379 2026-05-06

I-SPY

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
5,000 enrolled
BreastSarcoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT07193394 2026-02-23

H3RAKLES

Institut Curie

Phase 2 Recruiting
20 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡